AnaptysBio annual meeting: directors elected, KPMG ratified, equity plan amended

ANAPTYSBIO, INC

Stockholders elected Hollings Renton (15,304,522 for) and John P. Schmid (20,314,669 for) as Class III directors for 3-year terms.
Ratified KPMG LLP as independent auditor for fiscal year ending June 30, 2027: 22,343,352 votes for.
Advisory say-on-pay approved: 21,274,791 votes for; 609,979 against.
Approved amendment to 2017 Equity Incentive Plan extending term 10 years from Aug 11, 2026 and capping non-employee director comp at $1M (first year) / $750K (subsequent years).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.